10.04.12
Dr. Werner Lanthaler, chief executive officer of Evotec, will temporarily stand down from his role due to health reasons. Dr. Cord Dohrmann, chief scientific officer and Colin Bond, chief financial officer, will lead the company in Dr. Lanthaler’s absence.